Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study

Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study

Abstract Background With previously established efficacy of aripiprazole once-monthly injectable formulation (AOM) in pre-registration randomized controlled trials, the current study was designed to evaluate its effectiveness in patients treated for schizophrenia in regular clinical settings in Cana...

Full description

Bibliographic Details
Main Authors: Sally Mustafa, Joanna Bougie, Maia Miguelez, Guerline Clerzius, Emmanouil Rampakakis, Jean Proulx, Ashok Malla
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Psychiatry
Subjects:
Long acting injectable antipsychotics
Aripiprazole once-monthly
Global functioning
Adherence
Schizophrenia
Online Access:http://link.springer.com/article/10.1186/s12888-019-2103-x

Internet

http://link.springer.com/article/10.1186/s12888-019-2103-x

Similar Items